Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Deciding which card is better, cash back or rewards, requires consideration of your spending habits. Make the right choice for your finances.
26,157 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A viral nine-second clip about two bottles pouring into each other sparked a global conversation. This article transl...
A glossy online romance with a powerful royal figure can feel thrilling—until the bills arrive. This article explains...
U.S. corporations are accelerating stock repurchases, widening participation beyond mega-cap tech and triggering a br...
In early 2026, brokerages began shifting recruitment emphasis from commission splits to culture, mentorship, and infr...
CoreWeave’s billion funding haul underscores a shifting liquidity landscape, with AI infrastructure drawing tens of b...
Canopy Growth just made a bold move aimed at turning around years of underperformance. This article breaks down the d...
Amcor has quietly moved higher in recent months, offering a steady income play in a volatile market. In this guide, w...
This guide breaks down ameresco (amrc) 2025 earnings, what drives results, and how investors can position themselves ...
Is DraftKings stock analysis signaling a sell or a hold? This deep dive breaks down how regulation, competition, and ...
What happens when the urge to profit from other people’s drama collides with real-life costs? This article breaks dow...
Rising prices can feel overwhelming, but smart budgeting and loan moves can help you stay on track. This guide shares...